Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer
This study is ongoing, but not recruiting participants.
Study NCT00043004 Information provided by National Cancer Institute (NCI)
First Received: August 5, 2002 Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Cancer
Metastatic Cancer
Additional conditions recognized in this trial
Colorectal Neoplasms
Liver Neoplasms
Neoplasm Metastasis
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Liver Diseases
Neoplasms
Neoplasms by Site
Neoplastic Processes
Pathologic Processes
Rectal Diseases
Interventions listed in this trial
bevacizumab
FOLFOX regimen
fluorouracil
leucovorin calcium
oxaliplatin
conventional surgery
radiofrequency ablation
Additional drug interventions recognized in this trial
Leucovorin
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Immunologic Factors
Immunosuppressive Agents
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vitamin B Complex
Vitamins
Sponsors listed in this trial
European Organization for Research and Treatment of Cancer
Arbeitsgruppe Lebermetastasen und Tumoren
Institute of Cancer Research, United Kingdom
Back to top of Main Content
